OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 162 filers reported holding OREXIGEN THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $26,129,000 | +16.3% | 5,278,672 | +83.9% | 0.66% | +6.8% |
| Q1 2015 | $22,476,000 | +16.6% | 2,870,492 | -9.7% | 0.62% | +37.8% |
| Q4 2014 | $19,269,000 | -6.5% | 3,179,762 | -34.3% | 0.45% | -5.1% |
| Q3 2014 | $20,611,000 | -27.6% | 4,838,324 | +5.1% | 0.47% | -16.7% |
| Q2 2014 | $28,459,000 | -14.6% | 4,604,958 | -10.2% | 0.57% | -5.8% |
| Q1 2014 | $33,339,000 | +17.3% | 5,129,129 | +1.6% | 0.60% | +5.8% |
| Q4 2013 | $28,415,000 | +29.4% | 5,047,119 | +40.8% | 0.57% | +7.9% |
| Q3 2013 | $21,966,000 | +3.1% | 3,583,342 | -1.7% | 0.53% | +19.4% |
| Q2 2013 | $21,312,000 | +49.3% | 3,646,260 | +59.9% | 0.44% | -6.1% |
| Q1 2013 | $14,273,000 | – | 2,280,053 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 3,000,000 | $5,160,000 | 4.58% |
| Foresite Capital Management II, LLC | 6,225,049 | $10,707,000 | 3.59% |
| Scale Management, LLC | 1,312,575 | $2,258,000 | 3.46% |
| NEA Management Company, LLC | 3,709,000 | $6,379,000 | 0.41% |
| Cheyne Capital Management (UK) LLP | 413,200 | $709,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,189,000 | $2,045,000 | 0.31% |
| SAMLYN CAPITAL, LLC | 6,160,417 | $10,596,000 | 0.22% |
| Rock Springs Capital Management LP | 1,650,000 | $2,838,000 | 0.22% |
| Palo Alto Investors LP | 1,673,024 | $2,878,000 | 0.16% |
| GLOBEFLEX CAPITAL L P | 295,000 | $507,000 | 0.14% |